Bridgebio Oncology TherapeutBBOT
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 34 institutions reported holding Bridgebio Oncology Therapeut (BBOT) in their 13F filings, up 3 from Q1 2025. 7 opened new positions and 4 sold out. The largest holders were Cormorant Asset Management, LP ($30.9M), BlackRock, Inc. ($15.9M) and Citadel Advisors ($15.2M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Bridgebio Oncology Therapeut
- Filed as
- HELIX ACQUISITION CORP II (Q2 2025)
- CUSIP
- G4444H101
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $13.7M |
| Exits | 4 | $12.6M |
All 13F filers, Q1 2025 → Q2 2025: 1,935,792 shares bought and 1,706,753 shares sold, net +229,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Cormorant Asset Management, LP | 2.30% | No change | 2,909,000 | $30.9M |
| BlackRock, Inc. | 0.00% | No change | 1,498,865 | $15.9M |
| Citadel Advisors | 0.01% | Add +1.1% | 1,427,201 | $15.2M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | No change | 1,400,000 | $14.9M |
| T. Rowe Price Associates Inc. | 0.00% | No change | 1,071,550 | $11.4M |
| Millennium Management | 0.01% | Reduce -18.2% | 897,251 | $9.5M |
| Sculptor Capital LP | 0.22% | No change | 800,000 | $8.5M |
| Silverarc Capital Management, LLC | 1.33% | No change | 613,393 | $6.5M |
| Farallon Capital Management, L.L.C. | 0.03% | No change | 600,000 | $6.4M |
| Harraden Circle Investments, LLC | 1.71% | Add +8.2% | 569,831 | $6.1M |
| Berkley W R Corp. | 0.29% | New | 445,195 | $4.7M |
| Toronto Dominion Bank | 0.01% | Add +222.0% | 444,377 | $4.7M |
| ADAR1 Capital Management, LLC | 0.77% | Reduce -5.8% | 442,615 | $4.7M |
| Perceptive Advisors LLC | 0.16% | No change | 398,000 | $4.2M |
| Decagon Asset Management LLP | 2.93% | Add +45.5% | 348,223 | $3.7M |
| Stempoint Capital LP | 1.06% | Add +57.2% | 315,812 | $3.3M |
| Laurion Capital Management LP | 0.39% | No change | 300,000 | $3.2M |
| Shaolin Capital Management LLC | 0.82% | New | 292,338 | $3.1M |
| Octagon Capital Advisors LP | 0.58% | No change | 250,000 | $2.7M |
| JPMorgan Chase & Co. | 0.00% | Add +38.0% | 210,125 | $2.2M |
| Clear Street LLC | 0.01% | New | 205,666 | $2.2M |
| Creative Planning | 0.00% | New | 200,000 | $2.1M |
| Acuta Capital Partners, LLC | 2.78% | No change | 187,257 | $2.0M |
| Wellington Management Group LLP | 0.00% | No change | 184,590 | $2.0M |
| TD Asset Management Inc | 0.00% | No change | 144,772 | $1.5M |
| Hudson Bay Capital Management LP | 0.01% | New | 108,300 | $1.2M |
| Woodline Partners LP | 0.01% | No change | 103,247 | $1.1M |
| Moore Capital Management, LP | 0.02% | No change | 100,000 | $1.1M |
| K2 Principal Fund, L.P. | 0.46% | No change | 100,000 | $1.1M |
| UBS Group AG | 0.00% | Reduce -26.0% | 68,534 | $728K |
| Great Point Partners LLC | 0.20% | Reduce -92.1% | 29,381 | $312K |
| FNY Investment Advisers, LLC | 0.13% | New | 27,184 | $289K |
| Geode Capital Management, LLC | 0.00% | Add +0.4% | 13,328 | $142K |
| Fifth Lane Capital, LP | 0.14% | New | 10,500 | $112K |
"% of holder's portfolio" is BBOT's weight in each manager's 13F, not the share of Bridgebio Oncology Therapeut the manager owns.